Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF | V.TLT.W

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by CancerSlayeron Apr 04, 2023 11:32pm
204 Views
Post# 35380231

RE:RE:RE:RE:RE:Example of a jv deal

RE:RE:RE:RE:RE:Example of a jv deal

N0taP00p wrote: Well said, Slayer. I do agree with Eoganacht's point about more urologist eyeballs on this at a conference, but the power of a BTD fills the seats, so to speak, vs a poster presentation at a conference. I've been to many (non medical) conferences and most of the time, poster presentations are a gap filler. It's better than nothing but the crowds always migrate to the big things. Having BTD under your belt is a big thing. My 2 cents. 

 

Agree re: the impression a BTD or AA would make; however, getting significant data out to the public pre & post BTD/AA can sometimes have a more positive impact....becoming familiar with a new story & watching it develop to its conclusion can be a much more memorable/influential experience for those in the know.  For me, the importance/moral of the story sometimes gets lost if I skip right to the finale, especially a familiar one.

In our case, the plot of this story is at least unfolding for the public to see (though an abridged version) & the word is starting to spread.  A slow buildup often leads to a more grand/lasting finale.  Like my mother's stew, it seemed to simmer forever when hungry, but the wait was always worth it.  I'm thankful here that the burners are on, the data is stewing & now just waiting for the FDA to hand over the ladle...frankly, I've been licking my chops & am starving over here : ).

<< Previous
Bullboard Posts
Next >>